Mineralys Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Oct. 20, 2026, 5:32 p.m. ETView on SEC.gov
4Oct. 20, 2026, 5:35 p.m. ETView on SEC.gov
8-KOct. 19, 2026, 4:37 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
AI summary, unreviewedMineralys Therapeutics Adds Two Independent Directors, Expanding Board From Seven to Nine
4Oct. 2, 2026, 5:53 p.m. ETView on SEC.gov
4Sept. 24, 2026, 9:49 p.m. ETView on SEC.gov
4Sept. 22, 2026, 6:48 p.m. ETView on SEC.gov
4Sept. 17, 2026, 5:41 p.m. ETView on SEC.gov
4Aug. 25, 2026, 5:16 p.m. ETView on SEC.gov
4Aug. 12, 2026, 7:33 p.m. ETView on SEC.gov
4Aug. 12, 2026, 7:33 p.m. ETView on SEC.gov
10-QAug. 11, 2026, 5:18 p.m. ETView on SEC.gov
8-KAug. 11, 2026, 4:08 p.m. ETView on SEC.gov
Results of operations and financial condition · Departure/appointment of directors or officers · Financial statements and exhibits
SCHEDULE 13G/AAug. 6, 2026, 10:33 a.m. ETView on SEC.gov